Rodabe N. Amaria, MD

Melanoma Medical Oncology
Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center
Houston, Pennsylvania, United States

Presentation(s):

• BP1. Neoadjuvant Pembrolizumab in Stage IIB/C Melanoma: Updated Clinical Outcomes and Translational Data from Phase 2 Trial NCT03757689

  Friday, March 6, 2026
  8:02 AM - 8:09 AM MST